Identification and validation of core oxidative phosphorylation-related genes as biomarkers for immune response and diagnosis in burn injury - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Discovery and validation of essential oxidative phosphorylation-associated genes as indicators for immune response and diagnostic purposes in burn injuries

  • By

  • Jiaqi Xu

  • Yujie Cui

  • Kangdi Li

  • Jia Jia

  • Xinfeng Huang

  • August 12, 2026

Share

Clinical Report: Essential Oxidative Phosphorylation-Associated Genes in Burn Injuries

Overview

This study identifies 23 oxidative phosphorylation-related genes as potential biomarkers for immune response in burn injuries. Three core genes, ATP6V1C1, ECHS1, and LDHA, were validated for their roles in immune modulation.

Background

Burn injuries are a major global health issue, leading to severe trauma and significant systemic inflammatory responses. The identification of reliable biomarkers for early diagnosis and assessment of burn severity is critical.

Data Highlights

GeneRole
ATP6V1C1Involved in early immune response
ECHS1Modulates immune cell function
LDHAInvolved in early immune response

Key Findings

  • Identification of 23 differentially expressed oxidative phosphorylation-related genes in burn patients.
  • Core genes ATP6V1C1, ECHS1, and LDHA are associated with burn progression.
  • Group A patients showed heightened immune activity compared to Group B patients.
  • Knockdown of ATP6V1C1 or LDHA reduced pro-inflammatory cytokine secretion.
  • A diagnostic nomogram based on core genes demonstrated diagnostic capability.

Clinical Implications

The identified core genes may serve as potential molecular targets for enhancing prognosis in burn patients.

Conclusion

This study highlights oxidative phosphorylation-associated genes as biomarkers for immune response in burn injuries.

Related Resources & Content

  1. Frontiers in Surgery, 2026 -- Decoding the cGAS–STING–eosinophils predictive and natural therapeutic molecular signature in burn injury progression and keloid formation: insights from artificial intelligence-driven multiomics
  2. the analytical scientist, 2023 -- Deadly Burn Biomarkers
  3. Frontiers in Immunology, 2026 -- Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer
  4. Biomarkers of sepsis in burn injury: an update - PMC
  5. Archives of Toxicology — Induction of the Nrf2 Pathway by Hepatotoxic Medications is Linked to Inhibition of NF-κB Activation and Increased Vulnerability to TNFα-Induced Cell Death
  6. ISBI Burn Center Assessment Program Recommendations
  7. Biomarkers of sepsis in burn injury: an update - PMC

Original Source(s)

Related Content